{
    "xml": "<topic id=\"PHP3619\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/rifampicin\" basename=\"rifampicin\" title=\"RIFAMPICIN\">\n<title>RIFAMPICIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\">Rifampicin</xref>\n</p>\n<data name=\"vtmid\">29175007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_467467039\" title=\"Rifamycins\">Rifamycins</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP36801\" outputclass=\"indicationsAndDose\" rev=\"1.53\" parent=\"/drugs/rifampicin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Brucellosis in combination with other antibacterials</p>\n<p outputclass=\"therapeuticIndication\">Legionnaires disease in combination with other antibacterials</p>\n<p outputclass=\"therapeuticIndication\">Serious staphylococcal infections in combination with other antibacterials</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;11 months</p>\n<p>5&#8211;10&#8239;mg/kg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;17 years</p>\n<p>10&#8239;mg/kg twice daily (max. per dose 600&#8239;mg).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.6&#8211;1.2&#8239;g daily in 2&#8211;4 divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Endocarditis in combination with other drugs</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.6&#8211;1.2&#8239;g daily in 2&#8211;4 divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Tuberculosis, in combination with other drugs (intermittent supervised 6-month treatment) (under expert supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>15&#8239;mg/kg 3 times a week (max. per dose 900&#8239;mg) for 6 months (initial and continuation phases).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8211;900&#8239;mg 3 times a week for 6 months (initial and continuation phases).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Tuberculosis, in combination with other drugs (standard unsupervised 6-month treatment)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight up to 50 kg)</p>\n<p>15&#8239;mg/kg once daily for 6 months (initial and continuation phases); maximum 450&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight 50 kg and above)</p>\n<p>15&#8239;mg/kg daily for 6 months (initial and continuation phases); maximum 600&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 50 kg)</p>\n<p>450&#8239;mg daily for 6 months (initial and continuation phases).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50 kg and above)</p>\n<p>600&#8239;mg daily for 6 months (initial and continuation phases).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, in combination with isoniazid</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years (body-weight up to 50 kg)</p>\n<p>15&#8239;mg/kg daily for 3 months; maximum 450&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years (body-weight 50 kg and above)</p>\n<p>15&#8239;mg/kg daily for 3 months; maximum 600&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years (body-weight up to 50 kg)</p>\n<p>450&#8239;mg daily for 3 months.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 50 kg)</p>\n<p>450&#8239;mg daily for 3 months.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years (body-weight 50 kg and above)</p>\n<p>600&#8239;mg daily for 3 months.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50 kg and above)</p>\n<p>600&#8239;mg daily for 3 months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, who are isoniazid-resistant</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years (body-weight up to 50 kg)</p>\n<p>15&#8239;mg/kg daily for 6 months; maximum 450&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years (body-weight 50 kg and above)</p>\n<p>15&#8239;mg/kg daily for 6 months; maximum 600&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years (body-weight up to 50 kg)</p>\n<p>450&#8239;mg daily for 6 months.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years (body-weight 50 kg and above)</p>\n<p>600&#8239;mg daily for 6 months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, who are isoniazid-resistant and under 35 years</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;34 years (body-weight up to 50 kg)</p>\n<p>450&#8239;mg daily for 6 months.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;34 years (body-weight 50 kg and above)</p>\n<p>600&#8239;mg daily for 6 months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of secondary case of <ph outputclass=\"organism\">\n<i>\n<i>Haemophilus influenzae</i>\n</i>\n</ph> type b disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;2 months</p>\n<p>10&#8239;mg/kg once daily for 4 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 3 months&#8211;11 years</p>\n<p>20&#8239;mg/kg once daily (max. per dose 600&#8239;mg) for 4 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>600&#8239;mg once daily for 4 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg once daily for 4 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of secondary case of meningococcal meningitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;11 months</p>\n<p>5&#8239;mg/kg every 12&#8239;hours for 2 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;11 years</p>\n<p>10&#8239;mg/kg every 12&#8239;hours (max. per dose 600&#8239;mg), for 2 days.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>600&#8239;mg every 12&#8239;hours for 2 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg every 12&#8239;hours for 2 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Multibacillary leprosy in combination with dapsone and clofazimine (3-drug regimen)</p>\n<p outputclass=\"therapeuticIndication\">Paucibacillary leprosy in combination with dapsone (2-drug regimen)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 35 kg)</p>\n<p>450&#8239;mg once a month, supervised administration.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 35 kg and above)</p>\n<p>600&#8239;mg once a month, supervised administration.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36766\" outputclass=\"unlicensedUse\" rev=\"1.15\" parent=\"/drugs/rifampicin\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Not licensed for use in children for pruritus due to cholestasis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36827\" outputclass=\"contraindications\" rev=\"1.15\" parent=\"/drugs/rifampicin\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">jaundice</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP36832\" outputclass=\"cautions\" rev=\"1.22\" parent=\"/drugs/rifampicin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Discolours soft contact lenses</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36797\" outputclass=\"interactions\" rev=\"1.13\" parent=\"/drugs/rifampicin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (rifamycins).</p>\n<p>Rifampicin induces hepatic enzymes which accelerate the metabolism of several drugs including oestrogens, corticosteroids, phenytoin, sulfonylureas, and anticoagulants.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36779\" outputclass=\"sideEffects\" rev=\"1.26\" parent=\"/drugs/rifampicin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acute renal failure</ph>; <ph outputclass=\"sideEffect\">adrenal insufficiency</ph>; <ph outputclass=\"sideEffect\">alterations of liver function</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">antibiotic-associated colitis</ph>; <ph outputclass=\"sideEffect\">body secretions coloured orange-red</ph>; <ph outputclass=\"sideEffect\">collapse and shock</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">disseminated intravascular coagulation</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">eosinophilia</ph>; <ph outputclass=\"sideEffect\">exfoliative dermatitis</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal symptoms</ph>; <ph outputclass=\"sideEffect\">haemolytic anaemia</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms (with chills, fever, dizziness, bone pain)</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">menstrual disturbances</ph>; <ph outputclass=\"sideEffect\">muscular weakness</ph>; <ph outputclass=\"sideEffect\">myopathy</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">pemphigoid reactions</ph>; <ph outputclass=\"sideEffect\">psychoses</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">respiratory symptoms</ph>; <ph outputclass=\"sideEffect\">saliva coloured orange-red</ph>; <ph outputclass=\"sideEffect\">shortness of breath</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">thrombocytopenic purpura</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>; <ph outputclass=\"sideEffect\">urine coloured orange-red</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">thrombophlebitis reported if infusion used for prolonged period</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>Discontinue permanently if serious side-effects develop.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Intermittent therapy</p>\n<p>Side-effects that mainly occur with intermittent therapy include influenza-like symptoms (with chills, fever, dizziness, bone pain), respiratory symptoms (including shortness of breath), collapse and shock, haemolytic anaemia, thrombocytopenic purpura, disseminated intravascular coagulation, and acute renal failure</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36838\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.12\" parent=\"/drugs/rifampicin\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityContraindications\">\n<sectiondiv>\n<p>Contra-indicated in patients with rifamycin hypersensitivity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36828\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/rifampicin\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"title\">Important</p>\n<p>Effectiveness of hormonal contraceptives is reduced and alternative family planning advice should be offered.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36796\" outputclass=\"pregnancy\" parent=\"/drugs/rifampicin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturers advise very high doses teratogenic in <i>animal</i> studies in first trimester; risk of neonatal bleeding may be increased in third trimester.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36837\" outputclass=\"breastFeeding\" parent=\"/drugs/rifampicin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount too small to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36817\" outputclass=\"hepaticImpairment\" parent=\"/drugs/rifampicin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Avoid or do not exceed 8&#8239;mg/kg daily.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Impaired elimination.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInHepaticImpairment\">\n<sectiondiv>\n<p>In patients with pre-existing liver disease or hepatic impairment, monitor liver function regularly and particularly frequently in the first 2 months; blood counts should also be monitored in these patients.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36790\" outputclass=\"renalImpairment\" parent=\"/drugs/rifampicin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Use with caution if doses above 10&#8239;mg/kg daily.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Use with caution if dose above 600&#8239;mg daily.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36761\" outputclass=\"monitoringRequirements\" parent=\"/drugs/rifampicin\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>\n<i>Renal function</i> should be checked before treatment.</p>\n<p>\n<i>Hepatic function</i> should be checked before treatment. If there is no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment. However, liver function should be monitored on prolonged therapy.</p>\n<p>Blood counts should be monitored in patients on prolonged therapy.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Those with alcohol dependence should have frequent checks of hepatic function, particularly in the first 2 months. Blood counts should also be monitored in these patients.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36842\" outputclass=\"directionsForAdministration\" rev=\"1.12\" parent=\"/drugs/rifampicin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Rifadin</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%; reconstitute with solvent provided then dilute with 500&#8239;mL infusion fluid; give over 2&#8211;3 hours.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Displacement value may be significant, consult local reconstitution guidelines; reconstitute with solvent provided. May be further diluted with Glucose 5% <i>or</i> Sodium chloride 0.9% to a final concentration of 1.2&#8239;mg/mL. Infuse over 2&#8211;3 hours.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58405\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.34\" parent=\"/drugs/rifampicin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>If treatment interruption occurs, re-introduce with low dosage and increase gradually.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>In general, doses should be rounded up to facilitate administration of suitable volumes of liquid or an appropriate strength of tablet. Doses may also need to be recalculated to allow for weight gain in younger children.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Flavours of syrup may include raspberry.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36793\" outputclass=\"patientAndCarerAdvice\" rev=\"1.24\" parent=\"/drugs/rifampicin\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Rifampicin for meningococcal prophylaxis</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis\">www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis</xref>\n</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Rifampicin for the treatment of tuberculosis</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis\">www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"title\">Soft contact lenses</p>\r\n<p>Patients or their carers should be advised that rifampicin discolours soft contact lenses.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Hepatic disorders</p>\r\n<p>Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP3619-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/rifampicin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74972\" title=\"Capsule\" namespace=\"/drugs/rifampicin/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74996\" title=\"Oral suspension\" namespace=\"/drugs/rifampicin/oral-suspension\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74985\" title=\"Powder and solvent for solution for infusion\" namespace=\"/drugs/rifampicin/powder-and-solvent-for-solution-for-infusion\">Powder and solvent for solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85621\" namespace=\"/drugs/isoniazid-with-pyrazinamide-and-rifampicin\" title=\"ISONIAZID WITH PYRAZINAMIDE AND RIFAMPICIN\" count=\"1\" rel=\"backlink\">ISONIAZID WITH PYRAZINAMIDE AND RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85622\" namespace=\"/drugs/isoniazid-with-rifampicin\" title=\"ISONIAZID WITH RIFAMPICIN\" count=\"1\" rel=\"backlink\">ISONIAZID WITH RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP97002\" namespace=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\" title=\"ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN\" count=\"1\" rel=\"backlink\">ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97233\" namespace=\"/guidance/prescribing-in-hepatic-impairment\" title=\"Prescribing in hepatic impairment\" count=\"1\" rel=\"backlink\">Prescribing in hepatic impairment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78097\" namespace=\"/treatment-summaries/tetracyclines\" title=\"Tetracyclines\" count=\"1\" rel=\"backlink\">Tetracyclines</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78143\" namespace=\"/treatment-summaries/contraceptives-interactions\" title=\"Contraceptives, interactions\" count=\"4\" rel=\"backlink\">Contraceptives, interactions</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78210\" namespace=\"/treatment-summaries/antibacterials-use-for-prophylaxis\" title=\"Antibacterials, use for prophylaxis\" count=\"5\" rel=\"backlink\">Antibacterials, use for prophylaxis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78254\" namespace=\"/treatment-summaries/anthrax\" title=\"Anthrax\" count=\"1\" rel=\"backlink\">Anthrax</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78289\" namespace=\"/treatment-summaries/mrsa\" title=\"MRSA\" count=\"3\" rel=\"backlink\">MRSA</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78322\" namespace=\"/treatment-summaries/leprosy\" title=\"Leprosy\" count=\"4\" rel=\"backlink\">Leprosy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78330\" namespace=\"/treatment-summaries/tuberculosis\" title=\"Tuberculosis\" count=\"10\" rel=\"backlink\">Tuberculosis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78335\" namespace=\"/treatment-summaries/vaccines\" title=\"Vaccines\" count=\"1\" rel=\"backlink\">Vaccines</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78484\" namespace=\"/treatment-summaries/musculoskeletal-system-infections-bacterial\" title=\"Musculoskeletal system infections, bacterial\" count=\"3\" rel=\"backlink\">Musculoskeletal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78491\" namespace=\"/treatment-summaries/blood-infections-bacterial\" title=\"Blood infections, bacterial\" count=\"1\" rel=\"backlink\">Blood infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78553\" namespace=\"/treatment-summaries/central-nervous-system-infections-bacterial\" title=\"Central nervous system infections, bacterial\" count=\"2\" rel=\"backlink\">Central nervous system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78557\" namespace=\"/treatment-summaries/eye\" title=\"Eye\" count=\"1\" rel=\"backlink\">Eye</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"1\" rel=\"backlink\">Emergency treatment of poisoning</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78577\" namespace=\"/treatment-summaries/respiratory-system-infections-bacterial\" title=\"Respiratory system infections, bacterial\" count=\"2\" rel=\"backlink\">Respiratory system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78592\" namespace=\"/treatment-summaries/cardiovascular-system-infections-bacterial\" title=\"Cardiovascular system infections, bacterial\" count=\"4\" rel=\"backlink\">Cardiovascular system infections, bacterial</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\" title=\"Rifampicin\" count=\"1\" rel=\"link\">Rifampicin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74972\" namespace=\"/drugs/rifampicin/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74996\" namespace=\"/drugs/rifampicin/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74985\" namespace=\"/drugs/rifampicin/powder-and-solvent-for-solution-for-infusion\" title=\"Powder and solvent for solution for infusion\" count=\"1\" rel=\"link\">Powder and solvent for solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP3619",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/rifampicin",
    "basename": "rifampicin",
    "title": "RIFAMPICIN",
    "interactants": [
        {
            "id": "bnf_int_201",
            "label": "Rifampicin"
        }
    ],
    "vtmid": "29175007",
    "drugClassification": [
        "Rifamycins"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Brucellosis in combination with other antibacterials",
                        "html": "Brucellosis in combination with other antibacterials"
                    },
                    {
                        "textContent": "Legionnaires disease in combination with other antibacterials",
                        "html": "Legionnaires disease in combination with other antibacterials"
                    },
                    {
                        "textContent": "Serious staphylococcal infections in combination with other antibacterials",
                        "html": "Serious staphylococcal infections in combination with other antibacterials"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth or intravenous infusion"
                    ],
                    "textContent": "By mouth or by intravenous infusion",
                    "html": "By mouth or by intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "5&#8211;10 mg/kg twice daily.",
                        "html": "<p>5&#8211;10&#8239;mg/kg twice daily.</p>",
                        "ageGroup": "1&#8211;11 months"
                    },
                    {
                        "textContent": "10 mg/kg twice daily (max. per dose 600 mg).",
                        "html": "<p>10&#8239;mg/kg twice daily (max. per dose 600&#8239;mg).</p>",
                        "ageGroup": "1&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "0.6&#8211;1.2 g daily in 2&#8211;4 divided doses.",
                        "html": "<p>0.6&#8211;1.2&#8239;g daily in 2&#8211;4 divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Endocarditis in combination with other drugs",
                        "html": "Endocarditis in combination with other drugs"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth or intravenous infusion"
                    ],
                    "textContent": "By mouth or by intravenous infusion",
                    "html": "By mouth or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "0.6&#8211;1.2 g daily in 2&#8211;4 divided doses.",
                        "html": "<p>0.6&#8211;1.2&#8239;g daily in 2&#8211;4 divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Tuberculosis, in combination with other drugs (intermittent supervised 6-month treatment) (under expert supervision)",
                        "html": "Tuberculosis, in combination with other drugs (intermittent supervised 6-month treatment) (under expert supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "15 mg/kg 3 times a week (max. per dose 900 mg) for 6 months (initial and continuation phases).",
                        "html": "<p>15&#8239;mg/kg 3 times a week (max. per dose 900&#8239;mg) for 6 months (initial and continuation phases).</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "600&#8211;900 mg 3 times a week for 6 months (initial and continuation phases).",
                        "html": "<p>600&#8211;900&#8239;mg 3 times a week for 6 months (initial and continuation phases).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Tuberculosis, in combination with other drugs (standard unsupervised 6-month treatment)",
                        "html": "Tuberculosis, in combination with other drugs (standard unsupervised 6-month treatment)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "15 mg/kg once daily for 6 months (initial and continuation phases); maximum 450 mg per day.",
                        "html": "<p>15&#8239;mg/kg once daily for 6 months (initial and continuation phases); maximum 450&#8239;mg per day.</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "15 mg/kg daily for 6 months (initial and continuation phases); maximum 600 mg per day.",
                        "html": "<p>15&#8239;mg/kg daily for 6 months (initial and continuation phases); maximum 600&#8239;mg per day.</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "450 mg daily for 6 months (initial and continuation phases).",
                        "html": "<p>450&#8239;mg daily for 6 months (initial and continuation phases).</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "600 mg daily for 6 months (initial and continuation phases).",
                        "html": "<p>600&#8239;mg daily for 6 months (initial and continuation phases).</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, in combination with isoniazid",
                        "html": "Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, in combination with isoniazid"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "15 mg/kg daily for 3 months; maximum 450 mg per day.",
                        "html": "<p>15&#8239;mg/kg daily for 3 months; maximum 450&#8239;mg per day.</p>",
                        "ageGroup": "1 month&#8211;11 years (body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "15 mg/kg daily for 3 months; maximum 600 mg per day.",
                        "html": "<p>15&#8239;mg/kg daily for 3 months; maximum 600&#8239;mg per day.</p>",
                        "ageGroup": "1 month&#8211;11 years (body-weight 50 kg and above)"
                    },
                    {
                        "textContent": "450 mg daily for 3 months.",
                        "html": "<p>450&#8239;mg daily for 3 months.</p>",
                        "ageGroup": "12&#8211;17 years (body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "600 mg daily for 3 months.",
                        "html": "<p>600&#8239;mg daily for 3 months.</p>",
                        "ageGroup": "12&#8211;17 years (body-weight 50 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "450 mg daily for 3 months.",
                        "html": "<p>450&#8239;mg daily for 3 months.</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "600 mg daily for 3 months.",
                        "html": "<p>600&#8239;mg daily for 3 months.</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, who are isoniazid-resistant",
                        "html": "Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, who are isoniazid-resistant"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "15 mg/kg daily for 6 months; maximum 450 mg per day.",
                        "html": "<p>15&#8239;mg/kg daily for 6 months; maximum 450&#8239;mg per day.</p>",
                        "ageGroup": "1 month&#8211;11 years (body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "15 mg/kg daily for 6 months; maximum 600 mg per day.",
                        "html": "<p>15&#8239;mg/kg daily for 6 months; maximum 600&#8239;mg per day.</p>",
                        "ageGroup": "1 month&#8211;11 years (body-weight 50 kg and above)"
                    },
                    {
                        "textContent": "450 mg daily for 6 months.",
                        "html": "<p>450&#8239;mg daily for 6 months.</p>",
                        "ageGroup": "12&#8211;17 years (body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "600 mg daily for 6 months.",
                        "html": "<p>600&#8239;mg daily for 6 months.</p>",
                        "ageGroup": "12&#8211;17 years (body-weight 50 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, who are isoniazid-resistant and under 35 years",
                        "html": "Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive, who are isoniazid-resistant and under 35 years"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "450 mg daily for 6 months.",
                        "html": "<p>450&#8239;mg daily for 6 months.</p>",
                        "ageGroup": "18&#8211;34 years (body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "600 mg daily for 6 months.",
                        "html": "<p>600&#8239;mg daily for 6 months.</p>",
                        "ageGroup": "18&#8211;34 years (body-weight 50 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of secondary case of Haemophilus influenzae type b disease",
                        "html": "Prevention of secondary case of <ph outputclass=\"organism\"> <i> <i>Haemophilus influenzae</i> </i> </ph> type b disease",
                        "organism": "Haemophilus influenzae"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "Haemophilus influenzae"
                },
                "child": [
                    {
                        "textContent": "10 mg/kg once daily for 4 days.",
                        "html": "<p>10&#8239;mg/kg once daily for 4 days.</p>",
                        "ageGroup": "1&#8211;2 months"
                    },
                    {
                        "textContent": "20 mg/kg once daily (max. per dose 600 mg) for 4 days.",
                        "html": "<p>20&#8239;mg/kg once daily (max. per dose 600&#8239;mg) for 4 days.</p>",
                        "ageGroup": "3 months&#8211;11 years"
                    },
                    {
                        "textContent": "600 mg once daily for 4 days.",
                        "html": "<p>600&#8239;mg once daily for 4 days.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "600 mg once daily for 4 days.",
                        "html": "<p>600&#8239;mg once daily for 4 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of secondary case of meningococcal meningitis",
                        "html": "Prevention of secondary case of meningococcal meningitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "5 mg/kg every 12 hours for 2 days.",
                        "html": "<p>5&#8239;mg/kg every 12&#8239;hours for 2 days.</p>",
                        "ageGroup": "1&#8211;11 months"
                    },
                    {
                        "textContent": "10 mg/kg every 12 hours (max. per dose 600 mg), for 2 days.",
                        "html": "<p>10&#8239;mg/kg every 12&#8239;hours (max. per dose 600&#8239;mg), for 2 days.</p>",
                        "ageGroup": "1&#8211;11 years"
                    },
                    {
                        "textContent": "600 mg every 12 hours for 2 days.",
                        "html": "<p>600&#8239;mg every 12&#8239;hours for 2 days.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "600 mg every 12 hours for 2 days.",
                        "html": "<p>600&#8239;mg every 12&#8239;hours for 2 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Multibacillary leprosy in combination with dapsone and clofazimine (3-drug regimen)",
                        "html": "Multibacillary leprosy in combination with dapsone and clofazimine (3-drug regimen)"
                    },
                    {
                        "textContent": "Paucibacillary leprosy in combination with dapsone (2-drug regimen)",
                        "html": "Paucibacillary leprosy in combination with dapsone (2-drug regimen)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "450 mg once a month, supervised administration.",
                        "html": "<p>450&#8239;mg once a month, supervised administration.</p>",
                        "ageGroup": "(body-weight up to 35 kg)"
                    },
                    {
                        "textContent": "600 mg once a month, supervised administration.",
                        "html": "<p>600&#8239;mg once a month, supervised administration.</p>",
                        "ageGroup": "(body-weight 35 kg and above)"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Not licensed for use in children for pruritus due to cholestasis.",
                "html": "<p>Not licensed for use in children for pruritus due to cholestasis.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "jaundice",
                "html": "jaundice"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Discolours soft contact lenses",
                "html": "Discolours soft contact lenses"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (rifamycins).\n\nRifampicin induces hepatic enzymes which accelerate the metabolism of several drugs including oestrogens, corticosteroids, phenytoin, sulfonylureas, and anticoagulants.",
                "html": "<p>Appendix 1 (rifamycins).</p><p>Rifampicin induces hepatic enzymes which accelerate the metabolism of several drugs including oestrogens, corticosteroids, phenytoin, sulfonylureas, and anticoagulants.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Acute renal failure",
                        "html": "Acute renal failure",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "adrenal insufficiency",
                        "html": "adrenal insufficiency",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "alterations of liver function",
                        "html": "alterations of liver function",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "antibiotic-associated colitis",
                        "html": "antibiotic-associated colitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "body secretions coloured orange-red",
                        "html": "body secretions coloured orange-red",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "collapse and shock",
                        "html": "collapse and shock",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "disseminated intravascular coagulation",
                        "html": "disseminated intravascular coagulation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "eosinophilia",
                        "html": "eosinophilia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "exfoliative dermatitis",
                        "html": "exfoliative dermatitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal symptoms",
                        "html": "gastro-intestinal symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "haemolytic anaemia",
                        "html": "haemolytic anaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "influenza-like symptoms (with chills, fever, dizziness, bone pain)",
                        "html": "influenza-like symptoms (with chills, fever, dizziness, bone pain)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menstrual disturbances",
                        "html": "menstrual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscular weakness",
                        "html": "muscular weakness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myopathy",
                        "html": "myopathy",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oedema",
                        "html": "oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pemphigoid reactions",
                        "html": "pemphigoid reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "psychoses",
                        "html": "psychoses",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "respiratory symptoms",
                        "html": "respiratory symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "saliva coloured orange-red",
                        "html": "saliva coloured orange-red",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "shortness of breath",
                        "html": "shortness of breath",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombocytopenic purpura",
                        "html": "thrombocytopenic purpura",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urine coloured orange-red",
                        "html": "urine coloured orange-red",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "thrombophlebitis reported if infusion used for prolonged period",
                        "html": "thrombophlebitis reported if infusion used for prolonged period",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "Discontinue permanently if serious side-effects develop.",
                "html": "<p>Discontinue permanently if serious side-effects develop.</p>"
            },
            {
                "type": "advice",
                "title": "Intermittent therapy",
                "textContent": "Side-effects that mainly occur with intermittent therapy include influenza-like symptoms (with chills, fever, dizziness, bone pain), respiratory symptoms (including shortness of breath), collapse and shock, haemolytic anaemia, thrombocytopenic purpura, disseminated intravascular coagulation, and acute renal failure",
                "html": "<p>Side-effects that mainly occur with intermittent therapy include influenza-like symptoms (with chills, fever, dizziness, bone pain), respiratory symptoms (including shortness of breath), collapse and shock, haemolytic anaemia, thrombocytopenic purpura, disseminated intravascular coagulation, and acute renal failure</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Contra-indicated in patients with rifamycin hypersensitivity.",
                "html": "<p>Contra-indicated in patients with rifamycin hypersensitivity.</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "title": "Important",
                "textContent": "Effectiveness of hormonal contraceptives is reduced and alternative family planning advice should be offered.",
                "html": "<p>Effectiveness of hormonal contraceptives is reduced and alternative family planning advice should be offered.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturers advise very high doses teratogenic in animal studies in first trimester; risk of neonatal bleeding may be increased in third trimester.",
                "html": "<p>Manufacturers advise very high doses teratogenic in <i>animal</i> studies in first trimester; risk of neonatal bleeding may be increased in third trimester.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount too small to be harmful.",
                "html": "<p>Amount too small to be harmful.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Avoid or do not exceed 8 mg/kg daily.",
                "html": "<p>Avoid or do not exceed 8&#8239;mg/kg daily.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Impaired elimination.",
                "html": "<p>Impaired elimination.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "In patients with pre-existing liver disease or hepatic impairment, monitor liver function regularly and particularly frequently in the first 2 months; blood counts should also be monitored in these patients.",
                "html": "<p>In patients with pre-existing liver disease or hepatic impairment, monitor liver function regularly and particularly frequently in the first 2 months; blood counts should also be monitored in these patients.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Use with caution if doses above 10 mg/kg daily.",
                "html": "<p>Use with caution if doses above 10&#8239;mg/kg daily.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Use with caution if dose above 600 mg daily.",
                "html": "<p>Use with caution if dose above 600&#8239;mg daily.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Renal function should be checked before treatment.\n\nHepatic function should be checked before treatment. If there is no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment. However, liver function should be monitored on prolonged therapy.\n\nBlood counts should be monitored in patients on prolonged therapy.",
                "html": "<p>\n<i>Renal function</i> should be checked before treatment.</p><p>\n<i>Hepatic function</i> should be checked before treatment. If there is no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment. However, liver function should be monitored on prolonged therapy.</p><p>Blood counts should be monitored in patients on prolonged therapy.</p>"
            },
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Those with alcohol dependence should have frequent checks of hepatic function, particularly in the first 2 months. Blood counts should also be monitored in these patients.",
                "html": "<p>Those with alcohol dependence should have frequent checks of hepatic function, particularly in the first 2 months. Blood counts should also be monitored in these patients.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Rifadin ), give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute with solvent provided then dilute with 500 mL infusion fluid; give over 2&#8211;3 hours.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Rifadin</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%; reconstitute with solvent provided then dilute with 500&#8239;mL infusion fluid; give over 2&#8211;3 hours.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Displacement value may be significant, consult local reconstitution guidelines; reconstitute with solvent provided. May be further diluted with Glucose 5% or Sodium chloride 0.9% to a final concentration of 1.2 mg/mL. Infuse over 2&#8211;3 hours.",
                "html": "<p>Displacement value may be significant, consult local reconstitution guidelines; reconstitute with solvent provided. May be further diluted with Glucose 5% <i>or</i> Sodium chloride 0.9% to a final concentration of 1.2&#8239;mg/mL. Infuse over 2&#8211;3 hours.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "If treatment interruption occurs, re-introduce with low dosage and increase gradually.",
                "html": "<p>If treatment interruption occurs, re-introduce with low dosage and increase gradually.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "In general, doses should be rounded up to facilitate administration of suitable volumes of liquid or an appropriate strength of tablet. Doses may also need to be recalculated to allow for weight gain in younger children.",
                "html": "<p>In general, doses should be rounded up to facilitate administration of suitable volumes of liquid or an appropriate strength of tablet. Doses may also need to be recalculated to allow for weight gain in younger children.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of syrup may include raspberry.",
                "html": "<p>Flavours of syrup may include raspberry.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis",
                        "label": "www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Rifampicin for meningococcal prophylaxis",
                "textContent": "www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis\">www.medicinesforchildren.org.uk/rifampicin-for-meningococcal-prophylaxis</xref>\n</p>"
            },
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis",
                        "label": "www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Rifampicin for the treatment of tuberculosis",
                "textContent": "www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis\">www.medicinesforchildren.org.uk/rifampicin-for-treatment-of-tuberculosis</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Soft contact lenses",
                "textContent": "Patients or their carers should be advised that rifampicin discolours soft contact lenses.",
                "html": "<p>Patients or their carers should be advised that rifampicin discolours soft contact lenses.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "title": "Hepatic disorders",
                "textContent": "Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop.",
                "html": "<p>Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74972",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74996",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74985",
                "label": "Powder and solvent for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85621",
                "label": "ISONIAZID WITH PYRAZINAMIDE AND RIFAMPICIN",
                "type": "drug"
            },
            {
                "id": "PHP85622",
                "label": "ISONIAZID WITH RIFAMPICIN",
                "type": "drug"
            },
            {
                "id": "PHP97002",
                "label": "ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97233",
                "label": "Prescribing in hepatic impairment",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78097",
                "label": "Tetracyclines",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78143",
                "label": "Contraceptives, interactions",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78210",
                "label": "Antibacterials, use for prophylaxis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78254",
                "label": "Anthrax",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78289",
                "label": "MRSA",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78322",
                "label": "Leprosy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78330",
                "label": "Tuberculosis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78335",
                "label": "Vaccines",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78484",
                "label": "Musculoskeletal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78491",
                "label": "Blood infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78553",
                "label": "Central nervous system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78557",
                "label": "Eye",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78577",
                "label": "Respiratory system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78592",
                "label": "Cardiovascular system infections, bacterial",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_201",
                "label": "Rifampicin",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74972",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74996",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74985",
                "label": "Powder and solvent for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}